December 15th, 2015

Helicobacter Pylori Diagnostics Market 2020 Precise Outlook – Sekisui Diagnostics, Halyard Health, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, Medline Industries, EKF Diagnostics

By: X herald

Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2020-2025

The Helicobacter Pylori Diagnostics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.

Click the link to get a Sample Copy of the Report:

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Helicobacter Pylori Diagnostics Market: Sekisui Diagnostics, Halyard Health, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, Medline Industries, EKF Diagnostics, Thermo Fisher Scientific, Quidel, Alpha Laboratories, Cardinal Health, Coris BioConcept, Agilent Technologies, Beckman Coulter and others.

VENTANA anti-Helicobacter pylori (SP48) Rabbit Monoclonal Primary Antibody (VENTANA anti-H. pylori (SP48)) is designed to qualitatively detect the presence of Helicobacter pylori in formalin-fixed, paraffinembedded gastric biopsy tissue via light microscopy. Immunohistochemical staining with this antibody product may aid in the diagnosis of Helicobacter pylori infection. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.

March 16, 2020: Meridian Bioscience Announces FDA-Clearance for New Curian™ Analyzer and the Curian™ HpSA® Assay

CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of immunoassay, molecular, and blood chemistry diagnostic testing solutions, today announced that it has received FDA-clearance for Meridian’s new Curian™ and Curian™ HpSA® assay. This analyzer and first assay play an important part in their initiative to maintain leadership in the gastrointestinal disease testing market.

Curian and Curian HpSA are designed to quickly detect Helicobacter pylori antigens in human stool using immunofluorescent technology. Curian HpSA is intended to aid in the diagnosis of H. pylori infection and to demonstrate loss of H. pylori antigen following treatment (i.e., confirmation of eradication). With a simple workflow and clean, comfortable sample handling; Curian HpSA provides healthcare systems a platform looking to standardize H. pylori testing from the industry’s leading experts in stool handling and testing.

The immunofluorescent technology of the Curian platform provides an objective, rapid H. pylori result with state-of-the-art clinical sensitivity, specificity, and a lower limit of detection than traditional rapid immunoassay testing. Combined with LIS connectivity, the Curian solution helps to eliminate subjectivity by reducing user variability related to interpreting and reporting visually based test results.  “This is the first new platform internally developed at Meridian in several years,” said Dr. Larry Mertz, Senior Vice President of Research and Development / Clinical, “and the first of many new products we have in the pipeline continuing Meridian’s rich history of innovation.”

Meridian Bioscience offers an unparalleled H. pylori portfolio that accommodates any laboratory setting from low volume rapid testing to high volume automation, including the LIAISON® Meridian H. pylori SA test. Jack Kenny, Chief Executive Officer, commented “Curian offers both competitive performance and reduced subjectivity with only a three-step workflow. This is yet another step Meridian is taking toward providing diagnostic platforms for healthcare systems looking to standardize testing, improve patient outcomes, and increase clinician satisfaction rates.”

Global Helicobacter Pylori Diagnostics Market Split By Product Type And Applications:

This report segments the global Helicobacter Pylori Diagnostics market on the basis of Types is:

    Invasive Techniques

    Non-invasive Techniques

On the basis of Application, the Global Helicobacter Pylori Diagnostics market is segmented into:

    Hospitals and Clinics

    Diagnostic Laboratories

The research study evaluates the overall size of the market, by making use of a bottom-up approach, wherein data for different industry verticals, and end-user industries and its applications across various product types have been recorded and predicted during the forecast period. These segments and sub-segments have been documented from the industry specialists and professionals, as well as company representatives, and are outwardly validated by analyzing previous years’ data of these segments and sub-segments for getting an accurate and complete market size.

Influence Of The Helicobacter Pylori Diagnostics Market Report:

-Comprehensive assessment of all opportunities and risk in the Helicobacter Pylori Diagnostics market.

– Helicobacter Pylori Diagnostics market recent innovations and major events.

-Detailed study of business strategies for growth of the Helicobacter Pylori Diagnostics market-leading players.

-Conclusive study about the growth plot of Helicobacter Pylori Diagnostics market for forthcoming years.

-In-depth understanding of Helicobacter Pylori Diagnostics market-particular drivers, constraints and major micro markets.

-Favourable impression inside vital technological and market latest trends striking the Helicobacter Pylori Diagnostics market.

The report has 150 tables and figures browse the report description and TOC:

What Are The Market Factors That Are Explained In The Report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Analytical Tools: The Global Helicobacter Pylori Diagnostics Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687 |

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.